Atjaunināt sīkdatņu piekrišanu

Essential Reviews in Geriatric Psychiatry 2022 ed. [Hardback]

Edited by , Edited by , Edited by , Edited by , Edited by
  • Formāts: Hardback, 442 pages, height x width: 235x155 mm, weight: 988 g, XXIV, 442 p., 1 Hardback
  • Izdošanas datums: 02-Apr-2022
  • Izdevniecība: Springer Nature Switzerland AG
  • ISBN-10: 3030949591
  • ISBN-13: 9783030949594
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 136,16 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 160,19 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 442 pages, height x width: 235x155 mm, weight: 988 g, XXIV, 442 p., 1 Hardback
  • Izdošanas datums: 02-Apr-2022
  • Izdevniecība: Springer Nature Switzerland AG
  • ISBN-10: 3030949591
  • ISBN-13: 9783030949594
Citas grāmatas par šo tēmu:
This book critically reviews 75 important published papers that influence the practice of geriatric psychiatry. This book will assist anyone who is interested in the care of older adults with psychiatric disorders. It was written by thought leaders who shape the way geriatric psychiatry is currently practiced in the United States. All the major psychiatric disorders in later life are covered including anxiety disorders, bipolar disorders, depressive disorders, neurocognitive disorders, psychotic disorders, sleep disorders, and substance use disorders. It also reviews important studies on suicides in late life and interventional procedures in geriatric psychiatry like the ECT, and also evaluates the adverse effects of psychotropic medications on older adults with psychiatric disorders.    



The editors of the book along with input from members of the teaching and training committee of the American Association for Geriatric Psychiatry (AAGP) have chosen 75 published papers from the field of geriatric psychiatry that they believe provides the highest knowledge-yield/impact for practicing clinicians and educators in the field of geriatric mental health. The AAGP is a national association that represents and serves its members and the field of geriatric psychiatry. These 75 papers are critically appraised by the members of AAGP using a standardized format and a summary of these papers and their practical application is provided by these experts. This information can be used by anyone who wants to learn about the field of geriatric psychiatry.
Part I Adverse Effects of Medications
1 Do Atypical Antipsychotics Cause Stroke?
3(6)
Jasmine C. Stephens
Erica C. Garcia-Pittman
2 Risk of Death with Atypical Antipsychotic Drug Treatment for Dementia: Meta-analysis of Randomized Placebo-Controlled Trials
9(6)
Sara J. Anderson
Peter Ureste
3 Meta-analysis of the Impact of Nine Medication Classes on Falls in Elderly Persons
15(6)
Jason Gandelman
Peter Ureste
4 The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-analysis of Randomized Placebo-Controlled Trials
21(8)
Peter Ureste
Chloe Cheng
5 Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials
29(6)
Sarah Kim
Tracey Holsinger
6 A Systematic Review and Meta-analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias
35(6)
Paroma Mitra
Part II Anxiety Disorders
7 Treatment of Panic Disorder in Older Adults: A Pilot Study Comparison of Alprazolam, Imipramine, and Placebo
41(6)
Colin M. Smith
Paul A. Riordan
8 Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results from an 8-Week Randomized, Placebo-Controlled Trial
47(6)
Pallavi Joshi
Rajesh R. Tampi
9 Efficacy and Tolerability of Duloxetine in Elderly Patients with Generalized Anxiety Disorder: A Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Studies
53(4)
Pallavi Joshi
Rajesh R. Tampi
10 Escitalopram for Older Adults with Generalized Anxiety Disorder: A Randomized Controlled Trial
57(6)
Pallavi Joshi
Rajesh R. Tampi
11 Meta-analysis Comparing Different Behavioral Treatments for Late-Life Anxiety
63(4)
Hudaisa Hafeez
Tracey Holsinger
12 Cognitive Behavior Therapy for Generalized Anxiety Disorder Among Older Adults in Primary Care: A Randomized Clinical Trial
67(6)
Jenny Nguyen
Seetha Chandrasekhara
13 Stepped-Care Prevention of Anxiety and Depression in Late Life: A Randomized Controlled Trial
73(6)
Jenny Nguyen
Seetha Chandrasekhara
14 A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder
79(4)
Charlotte M. Schwarz
Tracey Holsinger
15 Antidepressant Medication Augmented with Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
83(4)
Megan Tusken
Izabella Dutra de Abreu
Audrey Eichenberger
Daniela Vela
Mary Camp
16 A Meta-Analysis of Cognitive Functioning in Older Adults with PTSD
87(6)
Avee Champaneria
Kristin McArthur
17 Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis
93(8)
Aarti Gupta
Gagandeep K. Bhatia
Part III Bipolar Disorder
18 A Pilot Study of Standardized Treatment in Geriatric Bipolar Disorder
101(4)
Hanadi Ajam Oughli
Kalya Vardi
19 Differences in Clinical Features and Mental Health Service Use in Bipolar Disorder Across the Life Span
105(4)
Colin M. Smith
Kristin McArthur
20 Effect of Antidepressant Use on Admissions to Hospital Among Elderly Bipolar Patients
109(6)
Christopher Morrow
Sophia Wang
21 GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients with Bipolar Disorder
115(6)
Mohamed A. Soliman
Susan W. Lehmann
22 History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis
121(6)
Vahid Pasovic
Adan Aslam Khan
Andrew Wong
Esther Akinyemi
Part IV Delirium
23 A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Patients
127(6)
Adan Aslam Khan
Andrew Wong
Vahid Pasovic
Esther Akinyemi
24 Delirium in Elderly Patients and the Risk of Post-Discharge Mortality, Institutionalization, and Dementia: A Meta-Analysis
133(4)
Sarah Kim
Tracey Holsinger
25 Effectiveness of Multicomponent Nonpharmacological Delirium Interventions: A Meta-Analysis
137(6)
Vahid Pasovic
Adan Aslam Khan
Andrew Wong
Esther Akinyemi
26 Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis
143(4)
Pallavi Joshi
Rajesh R. Tampi
27 Interventions for Preventing Delirium in Older People in Institutional Long-Term Care
147(8)
Matthew Erisman
Marianne Klugheit
Part V Depressive Disorders
28 Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression: A Randomized Controlled Trial in Patients Older than 59 Years
155(6)
Maureen Waweru
Seetha Chandrasekhara
29 Continuation Treatment of Delusional Depression in Older Adults
161(6)
Maureen Waweru
Seetha Chandrasekhara
30 Reducing Suicidal Ideation and Depressive Symptoms in Depressed Older Primary Care Patients: A Randomized Controlled Trial
167(6)
Jenny Nguyen
Seetha Chandrasekhara
31 Remission in Depressed Geriatric Primary Care Patients: A Report from the PROSPECT Study
173(6)
Jenny Nguyen
Seetha Chandrasekhara
32 Executive Dysfunction and the Course of Geriatric Depression
179(4)
Clay Gueits
Padmapriya Marpuri
Rajesh R. Tampi
33 Maintenance Treatment of Major Depression in Old Age
183(6)
Sarah Kim
Tracey Holsinger
34 Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression
189(4)
Audrey Eichenberger
Izabella Dutra de Abreu
Daniela Vela
Megan Tusken
Mary Camp
35 Efficacy of Second-Generation Antidepressants in Late-Life Depression: A Meta-analysis of the Evidence
193(6)
Martin Witkin
Padmapriya Marpuri
Rajesh R. Tampi
36 A Double-Blind Randomized Controlled Trial of Olanzapine Plus Sertraline Versus Olanzapine Plus Placebo for Psychotic Depression: The Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
199(6)
Pallavi Joshi
Rajesh R. Tampi
37 Speed of Remission in Elderly Patients with Depression: Electroconvulsive Therapy Versus Medication
205(4)
Peter Ureste
38 A Systematic Review and Meta-analysis of Psychotherapy for Late-Life Depression
209(6)
Jason Gandelman
Peter Ureste
39 A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study
215(6)
Paul A. Parcon
Peter Ureste
40 Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study
221(6)
Alba E. Lara
Erica C. Garcia-Pittman
41 Improvement in Depression Is Associated with Improvement in Cognition in Late-Life Psychotic Depression
227(8)
Gregg A. Robbins-Welty
Paul A. Riordan
Part VI Electroconvulsive Therapy
42 Continuation/Maintenance Treatment with Nortriptyline Versus Combined Nortriptyline and ECT in Late-Life Psychotic Depression: A Two-Year Randomized Study
235(6)
Jennifer Tu
Paul A. Riordan
43 Safety and Utility of Acute Electroconvulsive Therapy for Agitation and Aggression in Dementia
241(6)
Padmapriya Marpuri
Martin Witkin
Rajesh R. Tampi
44 Electroconvulsive Therapy and Risk of Dementia in Patients with Affective Disorders: A Cohort Study
247(6)
Padmapriya Marpuri
Clay Gueits
Rajesh R. Tampi
45 Electroconvulsive Therapy and Risk of Dementia: A Nationwide Cohort Study in Taiwan
253(6)
Clay Gueits
Padmapriya Marpuri
Rajesh R. Tampi
Part VII Grief
46 Treatment of Complicated Grief in Elderly Persons: A Randomized Clinical Trial
259(8)
Jennie B. Davidow
Juan Carlos Urizar
Part VIII Pain Disorders
47 Association Between Psychological Interventions and Chronic Pain Outcomes in Older Adults: A Systematic Review and Meta-Analysis
267(8)
Michael G. Li
Erica C. Garcia-Pittman
Part IX Psychotic Disorders
48 A Randomized Controlled Trial of Cognitive Behavioral Social Skills Training for Middle-Aged and Older Outpatients with Chronic Schizophrenia
275(6)
Avee Champaneria
Paul A. Riordan
49 Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients with Schizophrenia: A Double-Blind, Placebo-Controlled Study with Six-Month Open-Label Extension
281(6)
Elizabeth Qin
Peter Ureste
50 Antipsychotic Treatment for Elderly People with Late-Onset Schizophrenia
287(4)
Christa DeFries
Peter Ureste
51 Schizophrenia and Risk of Dementia: A Meta-Analysis Study
291(4)
Andrew Wong
Vahid Pasovic
Adan Khan
Esther Akinyemi
52 Antipsychotic Treatment of Very Late-Onset Schizophrenia-Like Psychosis (ATLAS): A Randomized, Controlled, Double-Blind Trial
295(8)
William B. Smith
Peter Ureste
Part X Neurocognitive Disorders
53 Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer's Disease: A Meta-analysis
303(4)
Chadrick E. Lane
Michelle L. Conroy
54 Depression and Risk for Alzheimer's Disease: Systematic Review, Meta-analysis, and Metaregression Analysis
307(6)
Emily B. Phelps
Sandra Swantek
55 Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
313(6)
Emily B. Phelps
Sandra Swantek
56 Predictors of Progression from Mild Cognitive Impairment to Alzheimer's Disease
319(6)
Sarah Kim
Tracey Holsinger
57 Efficacy and Safety of Cognitive Enhancers for Patients with Mild Cognitive Impairment: A Systematic Review and Meta-analysis
325(6)
Emily B. Phelps
Sandra Swantek
58 Personality and Risk of Alzheimer's Disease: New Data and Meta-analysis
331(6)
Katherine Levine
59 Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-analysis
337
Emily B. Phelps
Sandra Swantek
60 Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-analysis
143(206)
Chadrick E. Lane
Michelle L. Conroy
61 Meta-analysis of Modifiable Risk Factors of Alzheimer's Disease
349(6)
Emily B. Phelps
Sandra Swantek
62 Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis
355(6)
Emily B. Phelps
Sandra Swantek
63 Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-analysis
361(6)
Emily B. Phelps
Sandra Swantek
64 Pharmacological Interventions for Apathy in Alzheimer's Disease
367(8)
Jasmine Singh
Marianne Klugheit
Part XI Sleep Disorders
65 Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
375(6)
Maureen Waweru
Seetha Chandrasekhara
66 Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial
381(6)
Andrew Tuck
Paul A. Riordan
67 Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials
387(6)
Miles Christensen
Paul A. Riordan
68 Cognitive Behavioral Therapy for Older Adults with Insomnia and Depression: A Randomized Controlled Trial in Community Mental Health Services
393(6)
Daniela Vela
Izabella Dutra de Abreu
Megan Tusken
Audrey Eichenberger
Mary Camp
Part XII Suicides
69 Medical Illness and the Risk of Suicide in the Elderly
399(6)
Andrew Wong
Vahid Pasovic
Adan Aslam Khan
Esther Akinyemi
70 The Risk of Suicide with Selective Serotonin Reuptake Inhibitors in the Elderly
405(8)
Adan Aslam Khan
Andrew Wong
Vahid Pasovic
Esther Akinyemi
Part XIII Substance Use Disorders
71 Naltrexone as an Adjunctive Treatment for Older Patients with Alcohol Dependence
413(4)
Paroma Mitra
72 Older Adult Patients with Both Psychiatric and Substance Abuse Disorders: Prevalence and Health Service Use
417(4)
Ankit Jain
Paroma Mitra
73 Five-Year Alcohol and Drug Treatment Outcomes of Older Adults Versus Middle-Aged and Younger Adults in a Managed Care Program
421(4)
Paroma Mitra
74 Treatment of Late-Life Depression Complicated by Alcohol Dependence
425(6)
Paroma Mitra
75 Screening and Brief Intervention for Substance Misuse Among Older Adults: The Florida BRITE Project
431(6)
Paroma Mitra
Index 437
Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP, Creighton University School of Medicine, Department of Psychiatry, Creighton, NE 

Dr. Tampi is the Professor and Chairman of the Department of Psychiatry at Creighton University School of Medicine, Omaha, Nebraska. He is also the Chairman of Catholic Health Initiatives (CHI) Behavioral Health Services, Omaha, Nebraska. Dr. Tampi maintains his appointment as an Adjunct Professor of Psychiatry at Yale School of Medicine, New Haven, Connecticut. He is a Past President of the American Association for Geriatric Psychiatry (AAGP).





Deena J. Tampi, MSN, MBA-HCA, RN, DFAAGP, Behavioral Health Advisory Group, Princeton, NJ, USA 





Ms. Tampi is the Co-Founder and Managing Principal, Behavioral Health Advisory Group, Princeton, New Jersey. Ms. Tampi is on the Board of Directors for the American Association for Geriatric Psychiatry. In addition, she is the Chairperson of the Membership Committee for the American Association for Geriatric Psychiatry.

Juan J. Young, MD, Yale School of Medicine, Geriatric Psychiatry, New Haven, CT



Dr. Young is a current Geriatric Psychiatry Fellow at the Yale School of Medicine, and he also serves in the AAGP Membership Committee.







Meera Balasubramaniam, MD, MPH, NYU Langone Health, Department of Psychiatry, New York, NY





Dr. Meera Balasubramaniam is a Clinical Assistant Professor and the Director of the Geriatric Psychiatry fellowship program at the New York University School of Medicine. She has served on the editorial board of Frontiers in Psychiatry, is an Associate member on the editorial board of the American Journal of Geriatric Psychiatry

Pallavi Joshi, DO, MA University of Arizona College of Medicine-Phoenix, Phoenix, AZ 

Dr. Pallavi Joshi is a Clinical Assistant Professor at University of Arizona College of Medicine-Phoenix and a geriatricpsychiatrist at Banner Alzheimer's Institute. She has served on the Board of Directors for the American Association for Geriatric Psychiatry and the Council of Geriatric Psychiatry for the American Psychiatric Association.